REMIFENTANIL HYDROCHLORIDE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Remifentanil Hydrochloride, and when can generic versions of Remifentanil Hydrochloride launch?

Remifentanil Hydrochloride is a drug marketed by Fresenius Kabi Usa, Hikma, and Nivagen Pharms Inc. and is included in three NDAs.

The generic ingredient in REMIFENTANIL HYDROCHLORIDE is remifentanil hydrochloride. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the remifentanil hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Remifentanil Hydrochloride

A generic version of REMIFENTANIL HYDROCHLORIDE was approved as remifentanil hydrochloride by FRESENIUS KABI USA on January 16^th, 2018.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for REMIFENTANIL HYDROCHLORIDE?
What are the global sales for REMIFENTANIL HYDROCHLORIDE?
What is Average Wholesale Price for REMIFENTANIL HYDROCHLORIDE?

Summary for REMIFENTANIL HYDROCHLORIDE

US Patents:	0
Applicants:	3
NDAs:	3
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	27
Clinical Trials:	722
Patent Applications:	324
DailyMed Link:	REMIFENTANIL HYDROCHLORIDE at DailyMed

Drug patent expirations by year for REMIFENTANIL HYDROCHLORIDE

Recent Clinical Trials for REMIFENTANIL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	N/A
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital	N/A
Cedars-Sinai Medical Center	Phase 2

See all REMIFENTANIL HYDROCHLORIDE clinical trials

Pharmacology for REMIFENTANIL HYDROCHLORIDE

Drug Class	Opioid Agonist
Mechanism of Action	Full Opioid Agonists

Anatomical Therapeutic Chemical (ATC) Classes for REMIFENTANIL HYDROCHLORIDE

N01AH	Opioid anesthetics
N01A	ANESTHETICS, GENERAL
N01	ANESTHETICS
N	Nervous system

Paragraph IV (Patent) Challenges for REMIFENTANIL HYDROCHLORIDE

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
ULTIVA	for Injection	remifentanil hydrochloride	1 mg/vial, 2 mg/vial and 5 mg/vial	020630	1	2013-12-27

US Patents and Regulatory Information for REMIFENTANIL HYDROCHLORIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Fresenius Kabi Usa	REMIFENTANIL HYDROCHLORIDE	remifentanil hydrochloride	INJECTABLE;INJECTION	206223-001	Jan 16, 2018	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Nivagen Pharms Inc	REMIFENTANIL HYDROCHLORIDE	remifentanil hydrochloride	INJECTABLE;INJECTION	215635-001	Jun 28, 2024	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hikma	REMIFENTANIL HYDROCHLORIDE	remifentanil hydrochloride	INJECTABLE;INJECTION	210594-001	Oct 13, 2020	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Nivagen Pharms Inc	REMIFENTANIL HYDROCHLORIDE	remifentanil hydrochloride	INJECTABLE;INJECTION	215635-002	Jun 28, 2024	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Fresenius Kabi Usa	REMIFENTANIL HYDROCHLORIDE	remifentanil hydrochloride	INJECTABLE;INJECTION	206223-002	Jan 16, 2018	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Fresenius Kabi Usa	REMIFENTANIL HYDROCHLORIDE	remifentanil hydrochloride	INJECTABLE;INJECTION	206223-003	Jan 16, 2018	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hikma	REMIFENTANIL HYDROCHLORIDE	remifentanil hydrochloride	INJECTABLE;INJECTION	210594-003	Oct 13, 2020	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration